Smooth Muscle Cell‐Derived Exosomal miR‐30a‐5p as a Novel Therapeutic Strategy for Erectile Dysfunction in Diabetes Mellitus
Andrology · 2026-09 · 14 (6) · 1669-1683
DOI: 10.1111/andr.70234 ↗At a glance
Journal article in Andrology, published online on 2026-04-16. Written by Jingyu Song and 7 co-authors. Institution: Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Major MEDLINE topics: MicroRNAs, Erectile Dysfunction, Exosomes, Myocytes, Smooth Muscle. Cited 2 times so far (Crossref); 44 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China.
Topics: Diabetes mellitus
Abstract (original language)
Background
Erectile dysfunction (ED) affects more than half of male patients with diabetes. Diabetes mellitus‐related ED (DMED) remains challenging to manage due to hyperglycemia‐induced apoptosis and fibrosis of corpus cavernosum smooth muscle cells (SMCs). Exosomes secreted by normal SMCs (NSMC‐EXOs) have emerged as promising therapeutic vectors. This study investigated the therapeutic role and molecular mechanism of NSMC‐EXO‐carried microRNA‐30a‐5p (miR‐30a‐5p) in DMED.
Methods
Erectile function in DMED rats treated with NSMC‐EXOs was assessed via electrophysiological testing. Exosomal miRNA profiles were characterized by sequencing, and potential target genes were identified through bioinformatic prediction. The interaction between miR‐30a‐5p and Calm1 was experimentally validated. Expression levels of miR‐30a‐5p, Calm1, and markers of apoptosis and fibrosis were examined in vivo and in vitro. MiR‐30a‐5p mimics and inhibitors were employed to confirm the regulatory mechanism.
Results
Administration of NSMC‐EXOs significantly restored erectile function in DMED rats. Sequencing revealed a marked enrichment of miR‐30a‐5p in NSMC‐EXOs compared with exosomes from high‐glucose‐treated SMCs. Calm1 was identified as a direct target of miR‐30a‐5p, with involvement in apoptotic and fibrotic signaling pathways. Both in vivo and in vitro studies demonstrated that NSMC‐EXO‐derived miR‐30a‐5p was efficiently internalized by SMCs, suppressed Calm1 expression, and inhibited activation of the Calm1‐AMPK‐JNK and Calm1‐CaMK2‐TGFβ1 cascades. Consequently, apoptosis and fibrosis of corpus cavernosum tissue under hyperglycemic conditions were alleviated. Importantly, these protective effects were abolished following miR‐30a‐5p inhibition, underscoring its pivotal role.
Conclusion
NSMC‐EXO‐derived miR‐30a‐5p protects against DMED by directly targeting Calm1 and attenuating pro‐apoptotic and pro‐fibrotic signaling. These findings provide mechanistic insight supporting the development of exosome‐based therapeutic approaches for DMED.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID profiles: Peng Hu, Jiaxin Wang, Wenchao Xu, Tao Wang, Jihong Liu, Yajun Ruan
Funding
- National Natural Science Foundation of China
Cite
APA
Song, J., Hu, P., Wang, J., Xu, W., Cui, K., Wang, T., Liu, J., & Ruan, Y. (2026). Smooth Muscle Cell‐Derived Exosomal miR‐30a‐5p as a Novel Therapeutic Strategy for Erectile Dysfunction in Diabetes Mellitus. Andrology, 14(6), 1669-1683. https://doi.org/10.1111/andr.70234
Vancouver
Song J, Hu P, Wang J, Xu W, Cui K, Wang T, et al. Smooth Muscle Cell‐Derived Exosomal miR‐30a‐5p as a Novel Therapeutic Strategy for Erectile Dysfunction in Diabetes Mellitus. Andrology. 2026;14(6):1669-1683. doi:10.1111/andr.70234
BibTeX
@article{Song2026,
author = {Song, Jingyu and Hu, Peng and Wang, Jiaxin and Xu, Wenchao and Cui, Kai and Wang, Tao and Liu, Jihong and Ruan, Yajun},
title = {Smooth Muscle Cell‐Derived Exosomal miR‐30a‐5p as a Novel Therapeutic Strategy for Erectile Dysfunction in Diabetes Mellitus},
journal = {Andrology},
year = {2026},
volume = {14},
number = {6},
pages = {1669--1683},
doi = {10.1111/andr.70234}
}
EUVIMED